Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
20 July 1970
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
documentation insufficient for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1970
Report date:
1970

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
The skin of the back, sides and abdomen of the rats were shaved. The compound (TBTO) was sprayed on a skin area averaging 3.8 x 10 cm, usin a Deska compressed air vaporizer and covered with a plastic film and adhesive plaster (Tesaband). After 24 hours the plastic film was removed, the application site washed with luke-warm tap water. The application area was examined again after 4 hours and there after once daily for 8 days.
GLP compliance:
no
Remarks:
Completed before GLP standards, but would have been GLP compliant
Limit test:
no

Test material

Constituent 1
Reference substance name:
Hexabutyl di-stannoxane
IUPAC Name:
Hexabutyl di-stannoxane
Constituent 2
Reference substance name:
21955
IUPAC Name:
21955
Details on test material:
Not available

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 88-115 g
- Housing: Caged, Macrolon type II with wire-mesh bottom
- Diet (e.g. ad libitum): Altromin R, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: 13 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-24 °C
- Humidity (%): 51-56%

Administration / exposure

Type of coverage:
occlusive
Vehicle:
CMC (carboxymethyl cellulose)
Details on dermal exposure:
TEST SITE
- Area of exposure: Back and abdomen
- % coverage: 3.8 x 10 cm area
- Type of wrap if used: plastic film and adhesive plaster

REMOVAL OF TEST SUBSTANCE
- Washing (if done): Washed with luke-warm tap water
- Time after start of exposure: 24 hours

TEST MATERIAL
- Concentration (if solution): 10 g in 100 g
- Constant volume or concentration used: yes

VEHICLE
- Amount(s) applied (volume or weight with unit): 0.5 carboxylmethyl cellulose, aq dest ad 100 mL
Duration of exposure:
24 hours
Doses:
One dose = 300 mg/kg
No. of animals per sex per dose:
10 male & 10 female
Control animals:
no
Details on study design:
- Duration of observation period following administration: 9 days
- Frequency of observations and weighing: once per day
- Necropsy of survivors performed: yes

The following body areas, apertures, cavities and organs were examined by inspection and/or palpation, using appropriate equipment (e.g., hand-lens, stereoscopic microscope, instruments) in the course of assessing the nutritional state and cause of death, in all animals:

(1) Hairy pelt and
(2) Skin
Bodily apertures
(3) Eyes and conjunctiva
(4) Nose
(5) Mouth
(6) Ears
(7) Anus
(8) Preputial aperture
(9) Vulva
(10) Subcut. conn. tissue
(11) Abdominal and
(12) Pelvic cavities and
(13) Peritoneum
(14) Oesophagus*
(15) Stomach
(16) Small intestine
(17) Large intestine
(18) Mesenteric lymph node
(19) Liver
(20) Pancreas
(21) Spleen
(22) Kidneys
(23) Urinary bladder
(24) Seminal vesicles
(25) Prostate
(26) Testes
(27) Epididymides
(28) Ovaries
(29) Uterus
(30) Vagina*
(31) Thoracic cavity and
(32) Pleura
(33) Heart
(34) Lungs
(35) Trachea
(36) Thymus
(37) Cerebrum*
(38) Middle ear
(39) Site of administration

* Only where there is suspicion of pathological change as a result of the toxicity pattern, or other Special pathological findings.
Only pathological changes are recorded, with a note of their localisation, size or quantity, colour, surface area, section surface, consistency and/or diagnosis, in all animals, sub-divided in dose-groups
Statistics:
No information

Results and discussion

Preliminary study:
No information
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 300 mg/kg bw
Mortality:
None
Clinical signs:
other: Apathy began a few hours after application and persisted to the 4th day. From day 5 onwards, erythema and swelling were observed at the application site. All animals survived a dose of approximately 300 mg/kg. Dry necrosis of the skin was found at the app
Gross pathology:
On male had dry necrosis of skin of back at site of application. Two females had reddish scabbed areas up to the size of a five-penny piece on the ventral skin. Two females had hard and dry ventral skin.

Applicant's summary and conclusion

Conclusions:
LD50 (epidermal) > 300 mg/kg
Executive summary:

The skin of the back sides and abdomen of the rats was shaved. The compound (ZK 21,955 was sprayed on a skin area averaging 3.8 x 10 cm, using a Desaka compressed air vaporizer, and covered with a plastic film and adhesive plaster (Tesaband). A single application at a dose level of 300 mg/kg was applied. After 24 hours, the plastic film was removed, the application site was washed with luke-warm tap water. The application area was examined again after 4 hours and thereafter once daily until day 8. Apathy began a few hours after application and persisted to the 4th day. From day 5 onwards, erythema and swelling were observed at the application site. All animals survived a dose of approximately 300 mg/kg. Dry necrosis of the skin was found at the application site.